| EMA number | EMEA/H/C/002359 |
| ATC code | M05BA08 |
| Authorisation | 3 August 2012 |
| Withdrawn | 13 March 2026 |
| Revision | 15 |
Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone. Treatment of adult patients with tumour-induced hypercalcaemia (TIH).